SAMSUNG PHARM. Co., LTD. (KRX:001360)

SAMSUNG PHARM. Co., LTD. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Feb 20, 2025	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Market Capitalization	150,687	147,229	166,368	166,026	253,385	51,483
Market Cap Growth	-26.53%	-11.50%	0.21%	-34.48%	392.17%	97.11%
Enterprise Value	151,855	124,596	212,663	177,122	276,962	89,324
Last Close Price	1601.00	2282.64	3317.58	3453.75	7084.09	1751.77
PS Ratio	2.10	3.17	3.97	3.52	6.01	1.70
PB Ratio	0.70	1.12	1.77	2.02	5.48	2.21
P/TBV Ratio	1.16	1.12	1.78	2.08	6.70	2.23
P/OCF Ratio	-	-	32.29	-	-	-
EV/Sales Ratio	3.40	2.68	5.07	3.75	6.57	2.95
EV/EBITDA Ratio	-	-	-	-	455.17	-
Debt / Equity Ratio	0.11	0.14	0.48	0.54	1.61	1.12
Debt / EBITDA Ratio	-	-	-	-	122.71	-
Asset Turnover	0.27	0.30	0.29	0.35	0.45	-
Inventory Turnover	2.89	3.81	3.10	3.36	3.91	-
Quick Ratio	1.38	2.18	0.87	0.78	2.10	0.61
Current Ratio	2.38	3.10	1.17	1.31	2.54	0.91
Return on Equity (ROE)	-4.40%	-1.84%	-8.25%	-26.77%	-2.86%	-
Return on Assets (ROA)	-3.34%	-2.14%	-3.32%	-2.95%	-1.25%	-
Return on Capital (ROIC)	-3.60%	-2.33%	-3.66%	-3.20%	-1.37%	-
Earnings Yield	-3.95%	-1.41%	-4.53%	-13.02%	-0.39%	-46.13%
FCF Yield	-9.77%	-6.20%	-0.57%	-26.01%	-6.34%	-30.44%
Buyback Yield / Dilution	-24.91%	-28.44%	-21.80%	-28.46%	-40.00%	-126.18%
Total Shareholder Return	-24.91%	-28.44%	-21.80%	-28.46%	-40.00%	-126.18%

Source: S&P Capital IQ. Standard template. Financial Sources.